• LAST PRICE
    7.5900
  • TODAY'S CHANGE (%)
    Trending Up0.3250 (4.4735%)
  • Bid / Lots
    7.5900/ 1
  • Ask / Lots
    7.9900/ 1
  • Open / Previous Close
    7.2800 / 7.2650
  • Day Range
    Low 7.1900
    High 8.0650
  • 52 Week Range
    Low 2.1800
    High 13.6800
  • Volume
    515,309
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 7.265
TimeVolumeLRMR
09:32 ET16437.28
09:34 ET2007.385
09:41 ET11337.255
09:43 ET5007.25
09:48 ET1007.27
09:50 ET2007.3
09:52 ET1007.26
09:54 ET3007.295
09:56 ET1007.295
09:57 ET1007.24
09:59 ET10367.265
10:01 ET60217.22
10:03 ET119177.39
10:06 ET41207.39
10:08 ET66307.5
10:10 ET25917.54
10:12 ET202977.505
10:14 ET85867.63
10:15 ET88487.5934
10:17 ET31367.62
10:19 ET32407.6612
10:21 ET13507.68
10:24 ET37297.75
10:26 ET70597.74
10:28 ET13227.76
10:30 ET31577.77
10:32 ET83687.74
10:33 ET4007.74
10:35 ET4007.75
10:39 ET7007.75
10:42 ET15507.75
10:44 ET38807.77
10:46 ET3007.8
10:48 ET2307.785
10:50 ET6097.765
10:51 ET3007.765
10:53 ET10007.75
10:55 ET1807.77
10:57 ET6007.76
11:00 ET57127.76
11:06 ET12007.75
11:09 ET17907.75
11:11 ET2007.74
11:13 ET4007.75
11:15 ET2007.75
11:18 ET2007.75
11:20 ET35007.85
11:22 ET6507.86
11:24 ET1007.84
11:27 ET14817.82
11:29 ET7197.83
11:31 ET10647.83
11:33 ET12897.81
11:42 ET5557.78
11:44 ET2007.8
11:45 ET18097.78
11:47 ET2007.77
11:49 ET15007.86
11:54 ET1007.845
11:58 ET1007.845
12:00 ET2007.83
12:02 ET2007.8369
12:03 ET4007.88
12:05 ET12537.87
12:07 ET1007.8887
12:09 ET84487.9694
12:12 ET70008
12:14 ET5007.988
12:16 ET1037.98
12:18 ET1007.988
12:20 ET4007.99
12:21 ET1007.97
12:23 ET2007.96
12:25 ET42277.97
12:27 ET9188.01
12:30 ET13508.05
12:32 ET10008.06
12:34 ET3008.05
12:36 ET4008.0331
12:38 ET8008.03
12:39 ET35537.985
12:41 ET2007.97
12:43 ET7007.93
12:45 ET3007.93
12:48 ET1007.93
12:52 ET41747.93
12:54 ET25007.9
12:56 ET13327.96
12:57 ET3007.95
01:01 ET29867.9
01:03 ET6007.92
01:08 ET10007.93
01:10 ET1157.9699
01:12 ET1007.94
01:15 ET7097.95
01:19 ET5507.946
01:21 ET24007.9
01:24 ET10007.87
01:26 ET7007.85
01:28 ET2007.84
01:30 ET19567.855
01:32 ET7907.83
01:33 ET2007.8
01:39 ET3007.82
01:42 ET2007.8
01:44 ET12007.8
01:46 ET7007.79
01:48 ET5007.8
01:50 ET14007.81
01:51 ET4007.79
01:53 ET18007.78
01:55 ET8007.79
01:57 ET5007.81
02:00 ET22807.81
02:06 ET21007.815
02:08 ET36327.81
02:09 ET11047.81
02:11 ET8007.78
02:13 ET3007.76
02:15 ET310317.75
02:18 ET47257.76
02:20 ET4197.77
02:22 ET18387.76
02:24 ET2007.765
02:26 ET9397.7478
02:27 ET68797.74
02:29 ET21007.75
02:31 ET12107.75
02:36 ET1007.74
02:38 ET5007.74
02:40 ET15897.73
02:44 ET1007.735
02:45 ET1007.735
02:47 ET13907.75
02:49 ET3007.75
02:51 ET11007.74
02:54 ET4007.74
02:56 ET1007.72
02:58 ET16007.72
03:00 ET18007.72
03:02 ET38007.755
03:03 ET28947.71
03:05 ET72287.68
03:07 ET1007.7
03:09 ET11807.71
03:12 ET2007.7
03:14 ET14007.68
03:16 ET1007.66
03:18 ET20007.65
03:21 ET16237.62
03:25 ET6457.63
03:27 ET28007.62
03:30 ET52007.61
03:32 ET101027.65
03:34 ET29897.65
03:36 ET4007.65
03:38 ET40727.6
03:39 ET2037.58
03:41 ET17057.5908
03:43 ET13787.61
03:45 ET245777.55
03:48 ET29007.555
03:50 ET21007.56
03:52 ET41757.55
03:54 ET17177.56
03:56 ET30277.59
03:57 ET94197.59
03:59 ET109447.59
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLRMR
Larimar Therapeutics Inc
463.5M
-9.0x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
467.0M
-3.8x
---
United StatesOCGN
Ocugen Inc
456.6M
-5.1x
---
United StatesINZY
Inozyme Pharma Inc
456.5M
-5.5x
---
United StatesPEPG
PepGen Inc
455.9M
-4.4x
---
United StatesAEON
Aeon Biopharma Inc
452.6M
-15.0x
---
As of 2024-03-29

Company Information

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide (CPP) technology platform. The Company’s lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver tissue frataxin (FXN), an essential protein, to the mitochondria of patients with Friedreich's ataxia (FA). FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. Its CPP platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. It intends to use its proprietary platform to target additional orphan indications characterized by deficiencies in or alterations of intracellular content or activity.

Contact Information

Headquarters
THREE BALA PLAZA EAST. SUITE 506BALA CYNWYD, PA, United States 19004
Phone
617-622-4003
Fax
302-655-5049

Executives

Independent Chairman of the Board
Joseph Truitt
President, Chief Executive Officer, Director
Carole Ben-Maimon
Chief Financial Officer, Company Secretary
Michael Celano
Chief Medical Officer
Russell Clayton
Chief Development Officer
Gopi Shankar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$463.5M
Revenue (TTM)
$0.00
Shares Outstanding
63.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.95
EPS
$-0.84
Book Value
$1.86
P/E Ratio
-9.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.